The Scientist Awards Seahorse Bioscience XF96 Analyzer a Top Ten Innovation for 2009
Published: Dec 30, 2009
NORTH BILLERICA, Mass., Dec. 29 /PRNewswire/ -- Seahorse Bioscience, Inc., leader in the design and development of instruments for measuring cellular bioenergetics, announced that TheScientist magazine cited their XF96 Extracellular Flux Analyzer as a 2009 Top Ten Innovation.
"The XF Analyzers are revealing unexpected information about cellular respiration of cells that was not possible to attain before," noted John Lemasters, Director of the Center for Cell Death, Injury and Regeneration at the Medical University of South Carolina. "Insights from these findings are suggesting new strategies to rescue cells and tissues from irreversible toxic and ischemic injury."
"The XF Analyzer allows a scientist to see cancer cell metabolism in real time," stated Dr. Min Wu, Manager of Assay Development at Seahorse and author of several important cancer papers. "Studies utilizing the XF are revealing the metabolic dependencies of cancer cells on sugar and potential therapies. Scientists can determine whether a cancer is addicted to glucose (sugar) or glutamine, and establish which pathway to target for intervention."
One of TheScientist's judge's Dr. H. Steven Wiley, summed up the XF Analyzer's significance stating: "I want one!'
CONTACT: Cynthia Egan of Seahorse Bioscience, Inc., +1-978-671-1610
Web site: http://www.seahorsebio.com/